Inversago Pharma is a clinical-stage biotechnology company specializing in the development of peripherally-restricted CB1 receptor inverse agonists for metabolic disorders, including obesity and diabetes
Inversago Pharma is a clinical-stage biotechnology company specializing in the development of peripherally-restricted CB1 receptor inverse agonists for metabolic disorders, including obesity and diabetes.